Nothing Special   »   [go: up one dir, main page]

CA2417489A1 - Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure - Google Patents

Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure Download PDF

Info

Publication number
CA2417489A1
CA2417489A1 CA002417489A CA2417489A CA2417489A1 CA 2417489 A1 CA2417489 A1 CA 2417489A1 CA 002417489 A CA002417489 A CA 002417489A CA 2417489 A CA2417489 A CA 2417489A CA 2417489 A1 CA2417489 A1 CA 2417489A1
Authority
CA
Canada
Prior art keywords
indol
ethyl
substituted
carbamic acid
acetylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002417489A
Other languages
English (en)
French (fr)
Inventor
Maria A. Peral
Ward M. Peterson
Jesus J. Pintor
Benjamin R. Yerxa
Robert Plourde Jr.
Edward G. Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Inspire Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200001916A external-priority patent/ES2172415B2/es
Application filed by Individual filed Critical Individual
Publication of CA2417489A1 publication Critical patent/CA2417489A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002417489A 2000-07-28 2001-07-27 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure Abandoned CA2417489A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ES200001916A ES2172415B2 (es) 2000-07-28 2000-07-28 Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
ES200001916 2000-07-28
US27688501P 2001-03-16 2001-03-16
US60/276,885 2001-03-16
PCT/US2001/024220 WO2002009702A2 (en) 2000-07-28 2001-07-27 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure

Publications (1)

Publication Number Publication Date
CA2417489A1 true CA2417489A1 (en) 2002-02-07

Family

ID=26156193

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002417489A Abandoned CA2417489A1 (en) 2000-07-28 2001-07-27 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure

Country Status (9)

Country Link
EP (1) EP1307191A2 (es)
JP (1) JP2004518612A (es)
KR (1) KR20030046395A (es)
CN (1) CN1450896A (es)
AR (1) AR035651A1 (es)
AU (1) AU2001280984A1 (es)
CA (1) CA2417489A1 (es)
MX (1) MXPA03000729A (es)
WO (1) WO2002009702A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084128B2 (en) 2002-01-18 2006-08-01 Inspire Pharmaceuticals, Inc. Method for reducing intraocular pressure
ATE381333T1 (de) 2002-03-26 2008-01-15 Boehringer Ingelheim Pharma Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
PT1534313E (pt) 2002-07-30 2013-01-25 Omeros Corp Soluções e método de irrigação oftalmológica
US20040097574A1 (en) * 2002-08-29 2004-05-20 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
EP1753445A4 (en) 2004-05-06 2009-05-20 Molichem Medicines Inc TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
US7326683B2 (en) 2004-05-06 2008-02-05 Molichem Medicines, Inc. Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
ATE433958T1 (de) 2004-12-27 2009-07-15 Boehringer Ingelheim Pharma Glucocorticoid-mimetika, verfahren zu deren herstellung, pharmazeutische zusammensetzungen und deren verwendung
US8658637B2 (en) 2006-12-06 2014-02-25 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
EP2192917B1 (en) 2007-08-28 2014-01-29 Baxter International Inc. Method for producing viral vaccines
US8268859B2 (en) 2008-06-06 2012-09-18 Boehringer Ingelheim International Gmbh Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
CN102712584B (zh) * 2009-11-23 2014-10-29 阿勒根公司 晶型ii的7-[3,5-二羟基-2-(3-羟基-5-苯基-戊-1-烯基)-环戊基]-n-乙基-庚-5-烯酰胺(比马前列素)、其制备方法和使用方法
HUE030566T2 (en) 2010-01-11 2017-05-29 Inotek Pharmaceuticals Corp Combination, kit and method for reducing intraocular pressure
AU2011230580A1 (en) 2010-03-26 2012-10-11 Inotek Pharmaceuticals Corporation Method of reducing intraocular pressure in humans using N6 -cyclopentyladenosine (CPA), CPA derivatives or prodrugs thereof
US9278991B2 (en) 2012-01-26 2016-03-08 Inotek Pharmaceuticals Corporation Anhydrous polymorphs of [(2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)} methyl nitrate and processes of preparation thereof
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Surgical (Ireland) Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
EA201591433A1 (ru) 2013-03-15 2015-12-30 Инотек Фармасьютикалс Корпорейшн Офтальмологические составы
TWI809304B (zh) 2014-12-01 2023-07-21 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
BR112021006488A2 (pt) 2018-10-05 2021-07-06 Annapurna Bio Inc compostos e composições para o tratamento de condições associadas com atividade do receptor apj
JP2023539390A (ja) * 2020-09-02 2023-09-13 エンベリック バイオサイエンシズ カナダ インコーポレイテッド ニトロ化サイロシビン誘導体ならびに５－ｈｔ２ａ受容体を調節するためおよび精神障害を処置するためのその使用
WO2023044556A1 (en) 2021-09-24 2023-03-30 Enveric Biosciences Canada Inc. Aminated psilocybin derivatives and methods of using
WO2023078252A1 (en) 2021-11-02 2023-05-11 Flare Therapeutics Inc. Pparg inverse agonists and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
EP0375726A4 (en) * 1987-08-17 1991-01-30 Whitby Research Incorporated Melatonin analogues
GB9420529D0 (en) * 1994-10-12 1994-11-30 Pfizer Ltd Indoles
FR2737725B1 (fr) * 1995-08-08 1997-10-31 Valentonine Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament

Also Published As

Publication number Publication date
AR035651A1 (es) 2004-06-23
CN1450896A (zh) 2003-10-22
KR20030046395A (ko) 2003-06-12
WO2002009702A2 (en) 2002-02-07
WO2002009702A8 (en) 2003-05-08
WO2002009702A3 (en) 2002-12-27
MXPA03000729A (es) 2004-11-01
JP2004518612A (ja) 2004-06-24
EP1307191A2 (en) 2003-05-07
AU2001280984A1 (en) 2002-02-13

Similar Documents

Publication Publication Date Title
US6730707B2 (en) Method for reducing intraocular pressure using indole derivatives
CA2417489A1 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
JP6816180B2 (ja) 眼障害の治療のための組成物および方法
US4906467A (en) Novel, long-duration treatment for glaucoma
US6897201B2 (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
JP2007217437A (ja) カリウムチャンネル遮断剤の投与により、哺乳動物の眼圧を降下する方法
EA016227B1 (ru) Способ лечения офтальмологических неоваскулярных расстройств
EP1214062A2 (en) Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
JPH09508641A (ja) アンギオテンシン▲ｉｉ▼拮抗薬による正常眼圧緑内障の治療
US20050130931A1 (en) Compositions for the treatment of glaucoma or ocular hypertension
EP0502143B1 (en) Composition for treating ocular pain
WO1989010757A1 (en) New ophthalmic preparation for treating glaucoma
JPH10510289A (ja) 眼圧を降下するためのクロリドチャンネル遮断剤の使用
US5525601A (en) Composition for treating ocular pain
JP2844109B2 (ja) 眼疾患治療剤
US5196449A (en) Methods and pharmaceutical compositions for the treatment of ophthalmic diseases
US7084128B2 (en) Method for reducing intraocular pressure
EA012668B1 (ru) Окулоселективные лекарственные средства и пролекарства
WO2003051291A2 (en) Substituted 5-hydroxy-indole compounds for the treatment of glaucoma
WO2010056710A1 (en) Compositions and methods for treating eye diseases
US5153205A (en) Method to reduce introacular pressure without causing miosis
KR20100007983A (ko) 녹내장 및 근시 치료용 벤조 [ｇ] 퀴놀린 유도체
Sorbera et al. Bimatoprost
WO1998001099A2 (en) Method of treating retinal ischemia and glaucoma
JP2003505499A (ja) 緑内障の治療のための２−アミノテトラリン誘導体

Legal Events

Date Code Title Description
FZDE Dead